Frederic Pailloux manages projects involving the design and implementation of global regulatory strategies for the development, evaluation and marketing of small molecules and biologics.
Frederic is an enthusiastic Regulatory Affairs expert with 16 years of experience in the pharmaceutical industry. He has extensive experience in coordinating all aspects of Centralized submissions to the European Medicines Agency, and of Decentralized/Mutual Recognition procedures to EU National Health Authorities, from pre-filing dialogue stage to grant of marketing authorizations and beyond.
Prior to joining Voisin Consulting Life Sciences, Frederic led the development strategy of a wide range of products mainly in oncology, endocrinology and neurology, through all phases of clinical development. He has an in-depth knowledge of EU regulatory requirements including Paediatric Investigation Plans and Orphan Drug Designation applications and has prepared and driven several meetings with various Health Authorities/bodies, including Scientific Advice, in the EU and in the BRIC countries (mainly in Russia and Brazil).
Frederic has worked for large companies, Pierre Fabre Médicament and recently at Ipsen Pharma where, as Director Europe Coordination, he ensured EU contribution to global regulatory strategies and implementation plans, led operational regulatory activities for Europe and supervised tactical regulatory aspects for non-EU countries.
In addition, he has worked for Orphan Europe, where he successfully led Orphan Drug Designations and Marketing Authorization Applications, and ensured life-cycle maintenance activities.
Frederic earned his Pharm.D. degree from the University François Rabelais of Pharmacy in Tours, France. He also holds a post-graduate diploma in Health/Drug Law, Marketing and Management of Pharmaceutical Industries from the University of Bordeaux. He is based in Lausanne, Switzerland.